Chemoinformaics analysis of Spinacetin-3-0-Glucoside
| Molecular Weight | 508.432 | nRot | 6 |
| Heavy Atom Molecular Weight | 484.24 | nRig | 24 |
| Exact Molecular Weight | 508.122 | nRing | 4 |
| Solubility: LogS | -3.914 | nHRing | 2 |
| Solubility: LogP | -0.066 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 17 |
| nHA | 13 | APOL | 64.839 |
| nHD | 7 | BPOL | 33.625 |
| QED | 0.23 |
| Synth | 4.066 |
| Natural Product Likeliness | 2.03 |
| NR-PPAR-gamma | 0.942 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.052 |
| Pgp-sub | 0.961 |
| HIA | 0.789 |
| CACO-2 | -6.176 |
| MDCK | 0.0000201 |
| BBB | 0.073 |
| PPB | 0.788294 |
| VDSS | 0.963 |
| FU | 0.229266 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.295 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.31 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.194 |
| CYP3a4-inh | 0.061 |
| CYP3a4-sub | 0.02 |
| CL | 4.46 |
| T12 | 0.826 |
| hERG | 0.023 |
| Ames | 0.754 |
| ROA | 0.063 |
| SkinSen | 0.055 |
| Carcinogencity | 0.034 |
| EI | 0.016 |
| Respiratory | 0.026 |
| NR-Aromatase | 0.835 |
| Antiviral | Yes |
| Prediction | 0.86401 |